Cross Country Healthcare (CCRN) Tops Q4 EPS by 1c, Offers Q1 Guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q4 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $215.1 million versus the consensus estimate of $208.22 million.

GUIDANCE:

Cross Country Healthcare sees Q1 2020 EPS of ($0.03)-$0.00, versus the consensus of $0.02. Cross Country Healthcare sees Q1 2020 revenue of $207-212 million, versus the consensus of $207.3 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
• Home Depot (HD) Tops Q2 EPS by 19c, reaffirms guidance
• Baidu (BIDU) Misses Q2 EPS by 262c, misses on revenue